OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

All Filters

Clear
Clear
Clear
Clear
Clear
Clear
Clear
Investigator: Betty Tijms

1 Projects | 1 Researchers | $650,000 Invested

2024

Stichting Amsterdam UMC

Betty Tijms

Plasma proteomic approach to identify CSF defined molecular subtypes of Alzheimer’s disease for personalised treatment

  • Funding Amount: $650,000
  • Organization Type: Academic/Nonprofit
  • Program: Diagnostics Accelerator
  • Target: Other
  • Status: Active